|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...5960616263646566676869...110111» |
- Enrollment open, Trial primary completion date: Outcomes of Delivery in Patients With Dyspareunia (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=200, Recruiting, Sponsor: Hadassah Medical Organization
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015
- ||||| Visanne (dienogest) / Mochida, Bayer
Enrollment closed, Enrollment change: Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients (clinicaltrials.gov) - Sep 30, 2014
P3, N=175, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2014 --> Feb 2015 Recruiting --> Active, not recruiting | N=250 --> 175
- Trial primary completion date, HEOR: Sexual Functioning in Cervical Cancer Survivors (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=165, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Active, not recruiting | N=250 --> 175 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: DNA Array Analysis of Patients With Cervical Cancer (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=18, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy (clinicaltrials.gov) - Sep 30, 2014
P1/2, N=24, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- temozolomide / Generic mfg.
Trial completion: Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=16, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Trial primary completion date: Sep 2015 --> Sep 2016 Active, not recruiting --> Completed
- |||| carboplatin / Generic mfg., paclitaxel / Generic mfg., sorafenib / Generic mfg.
Trial completion, Trial primary completion date: Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 30, 2014
P2, N=85, Completed, Sponsor: SCRI Development Innovations, LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Oct 2014 --> Jul 2012
- || Enrollment closed: Detection of Chlamydia (CT) and Gonorrhea (NG) (clinicaltrials.gov) - Sep 29, 2014
P=N/A, N=700, Active, not recruiting, Sponsor: Meridian Bioscience, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Oct 2014 --> Jul 2012 Recruiting --> Active, not recruiting
- || MEDI-3617 / AstraZeneca
Enrollment change, Combination therapy, Metastases: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Sep 29, 2014
P1, N=120, Recruiting, Sponsor: MedImmune LLC
Recruiting --> Active, not recruiting N=170 --> 120
- atorvastatin / Generic mfg.
Trial completion: A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol (clinicaltrials.gov) - Sep 28, 2014
P2, N=20, Completed, Sponsor: Milton S. Hershey Medical Center
N=170 --> 120 Terminated --> Completed
- Enrollment change, Trial termination, Metastases: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=15, Terminated, Sponsor: University of British Columbia
Terminated --> Completed N=40 --> 15 | Recruiting --> Terminated; due to company changes and lack of funding-unlikely to have sufficient numbers to analyze meaningfully
- | New P4 trial: Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis (clinicaltrials.gov) - Sep 28, 2014
P4, N=60, Recruiting, Sponsor: Instituto Palacios
- || New P3 trial, Head-to-Head: GYNOCANS: Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis (clinicaltrials.gov) - Sep 28, 2014
P3, N=322, Recruiting, Sponsor: Probionov
- | New P2 trial: Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding (clinicaltrials.gov) - Sep 28, 2014
P2, N=106, Recruiting, Sponsor: Mostafa Hussein
- ||| Trial completion, Trial primary completion date: Total Versus Subtotal Abdominal Hysterectomy (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=319, Completed, Sponsor: Nykøbing Falster County Hospital
N=40 --> 15 | Recruiting --> Terminated; due to company changes and lack of funding-unlikely to have sufficient numbers to analyze meaningfully Enrolling by invitation --> Completed | Trial primary completion date: Dec 2013 --> Sep 2013
- ||||||| Trial completion, Head-to-Head: Lcr35® for Bacterial Vaginosis Prevention (clinicaltrials.gov) - Sep 28, 2014
P3, N=352, Completed, Sponsor: Laboratoires Lyocentre
Enrolling by invitation --> Completed | Trial primary completion date: Dec 2013 --> Sep 2013 Recruiting --> Completed
- cefazolin / Generic mfg., azithromycin / Generic mfg.
Enrollment change, Trial termination: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis (clinicaltrials.gov) - Sep 28, 2014
P4, N=9, Terminated, Sponsor: University of Missouri, Kansas City
Recruiting --> Completed N=506 --> 9 | Recruiting --> Terminated; Poor enrollment
- ||| Phase classification, Enrollment change: Alternate Dosing Schedules Study for HPV Vaccine (clinicaltrials.gov) - Sep 28, 2014
P4, N=72, Completed, Sponsor: Duke University
N=506 --> 9 | Recruiting --> Terminated; Poor enrollment Phase classification: P=N/A --> P4 | N=333 --> 72
- | carboplatin / Generic mfg., decitabine / Generic mfg.
Trial completion: Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer (clinicaltrials.gov) - Sep 28, 2014
P1/2, N=28, Completed, Sponsor: Indiana University
Phase classification: P=N/A --> P4 | N=333 --> 72 Active, not recruiting --> Completed
- || Trial primary completion date: Study of Vaginal Dilator Use After Pelvic Radiotherapy (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=115, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Trial primary completion date: Nov 2014 --> Nov 2015
- Trial initiation date, Trial primary completion date: High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection (clinicaltrials.gov) - Sep 28, 2014
P2, N=20, Not yet recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Nov 2014 --> Nov 2015 Initiation date: Jul 2014 --> Dec 2014 | Trial primary completion date: Jul 2017 --> Dec 2017
- Clinical: Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=110, Completed, Sponsor: Harokopio University
- | New P4 trial: Effects of Embryogen in RIF Patients (clinicaltrials.gov) - Sep 28, 2014
P4, N=60, Completed, Sponsor: Vietnam National University
- |||| Baxdela (delafloxacin) / Menarini, Melinta Therap
Trial primary completion date: Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea (clinicaltrials.gov) - Sep 22, 2014
P3, N=757, Recruiting, Sponsor: Melinta Therapeutics, Inc.
Initiation date: Jul 2014 --> Dec 2014 | Trial primary completion date: Jul 2017 --> Dec 2017 Trial primary completion date: Aug 2014 --> Nov 2014
- Trial primary completion date: A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART) (clinicaltrials.gov) - Sep 22, 2014
P=N/A, N=200, Recruiting, Sponsor: Virginia Center for Reproductive Medicine
Trial primary completion date: Aug 2014 --> Nov 2014 Trial primary completion date: Jun 2014 --> Dec 2014
- Clinical: Efficacy of Pergoveris in Aged IVF Patients (clinicaltrials.gov) - Sep 22, 2014
P=N/A, N=240, Completed, Sponsor: Vietnam National University
- Enrollment change, Trial termination, Trial primary completion date: The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve (clinicaltrials.gov) - Sep 22, 2014
P0, N=200, Terminated, Sponsor: Virginia Center for Reproductive Medicine
Trial primary completion date: Jun 2014 --> Dec 2014 N=100 --> 200 | Recruiting --> Terminated | Trial primary completion date: Jan 2014 --> Sep 2014; Suboptimal recruitment
- Trial completion, Trial primary completion date: VICAR2: Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women (clinicaltrials.gov) - Sep 22, 2014
P=N/A, N=166, Completed, Sponsor: University of Witwatersrand, South Africa
N=100 --> 200 | Recruiting --> Terminated | Trial primary completion date: Jan 2014 --> Sep 2014; Suboptimal recruitment Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Aug 2014
- Trial primary completion date, Surgery: Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=130, Recruiting, Sponsor: Swedish Medical Center
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Aug 2014 Trial primary completion date: Jun 2014 --> Dec 2014
- Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
P2 data, Enrollment change, Trial withdrawal: Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin (clinicaltrials.gov) - Sep 19, 2014
P2, N=0, Withdrawn, Sponsor: Andrea McCart
Trial primary completion date: Jun 2014 --> Dec 2014 N=25 --> 0 | Not yet recruiting --> Withdrawn
- ||||| clotrimazole topical / Generic mfg.
New P4 trial: Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis (clinicaltrials.gov) - Sep 19, 2014
P4, N=150, Not yet recruiting, Sponsor: Medinova AG
- | New P2 trial, HEOR: AdolCHICA: Improving Adolescent Health Outcomes Through Preventive Care Transformation (clinicaltrials.gov) - Sep 19, 2014
P2, N=2831, Recruiting, Sponsor: Indiana University
- || Enrollment closed: Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=2100, Active, not recruiting, Sponsor: Gen-Probe, Incorporated
N=25 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting
- | Trial completion: Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Sep 19, 2014
P1/2, N=38, Completed, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed | N=28 --> 38 | Recruiting --> Completed
- New P4 trial, MRI: MILO: Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer (clinicaltrials.gov) - Sep 19, 2014
P4, N=20, Not yet recruiting, Sponsor: Maastricht University Medical Center
- tranexamic acid oral / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=17, Completed, Sponsor: Baylor College of Medicine
Recruiting --> Completed | N=28 --> 38 | Recruiting --> Completed Active, not recruiting --> Completed | N=30 --> 17 | Trial primary completion date: Aug 2016 --> Jun 2013
- Trial completion, Enrollment change, Trial primary completion date: Flaxseed Lignan (Brevail) (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=9, Completed, Sponsor: University of Kansas
Active, not recruiting --> Completed | N=30 --> 17 | Trial primary completion date: Aug 2016 --> Jun 2013 Recruiting --> Completed | N=20 --> 9 | Trial primary completion date: Jun 2014 --> Dec 2013
- | Trial completion: Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic (clinicaltrials.gov) - Sep 19, 2014
P3, N=1010, Completed, Sponsor: The Miriam Hospital
Recruiting --> Completed | N=20 --> 9 | Trial primary completion date: Jun 2014 --> Dec 2013 Enrolling by invitation --> Completed
- davamotecan pegadexamer (EP0057) / Ellipses Pharma
Trial withdrawal: Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients (clinicaltrials.gov) - Sep 16, 2014
P2, N=0, Withdrawn, Sponsor: Cerulean Pharma Inc.
Enrolling by invitation --> Completed Terminated --> Withdrawn
- ||| Clinical data, Trial completion, Enrollment change: ESCORT: An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=10103, Completed, Sponsor: Merck KGaA
Terminated --> Withdrawn Recruiting --> Completed | N=8100 --> 10103
- Enrollment closed, Trial primary completion date: ASPIRE Pilot: Comparing Self-collected HPV Testing With Visual Inspection With Acetic Acid Screening for Cervical Cancer (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=500, Active, not recruiting, Sponsor: University of British Columbia
Recruiting --> Completed | N=8100 --> 10103 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> May 2014
- | clomifene citrate / Generic mfg.
New P4 trial: N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome (clinicaltrials.gov) - Sep 12, 2014
P4, N=70, Completed, Sponsor: Assiut University
- Enrollment open, Enrollment change, Trial initiation date, Metastases: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 12, 2014
P1, N=24, Recruiting, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> May 2014 Not yet recruiting --> Recruiting | N=42 --> 24 | Initiation date: Apr 2014 --> Aug 2014
- | azithromycin / Generic mfg.
Phase classification: RESCUE: Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=400, Enrolling by invitation, Sponsor: Pfizer
Not yet recruiting --> Recruiting | N=42 --> 24 | Initiation date: Apr 2014 --> Aug 2014 Phase classification: P4 --> P=N/A
- Clinical: Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=654, Completed, Sponsor: University of California, San Francisco
- | New P1 trial: Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer (clinicaltrials.gov) - Sep 11, 2014
P1, N=30, Recruiting, Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
- Menopur (menotropin) / Ferring
Trial initiation date: Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur (clinicaltrials.gov) - Sep 10, 2014
P=N/A, N=371, Completed, Sponsor: University Hospital, Gasthuisberg
Phase classification: P4 --> P=N/A Initiation date: Nov 2005 --> Sep 2004
- megestrol / Generic mfg.
Enrollment change, Trial withdrawal, Head-to-Head: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer (clinicaltrials.gov) - Sep 10, 2014
P2, N=0, Withdrawn, Sponsor: University of Southern California
Initiation date: Nov 2005 --> Sep 2004 N=130 --> 0 | Not yet recruiting --> Withdrawn
- |||||||||| VivaGel (astodrimer vaginal) / Starpharma
New P3 trial: Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) (clinicaltrials.gov) - Sep 10, 2014
P3, N=620, Recruiting, Sponsor: Starpharma Pty Ltd
- clomifene citrate / Generic mfg.
Clinical: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate. (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Ghent